We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

188 hedge funds and large institutions have $1.74B invested in Amedisys in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 74 increasing their positions, 53 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 15

40% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 53

37% more call options, than puts

Call options by funds: $2.52M | Put options by funds: $1.84M

15% more funds holding

Funds holding: 163188 (+25)

1.47% more ownership

Funds ownership: 95.97%97.44% (+1.5%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less capital invested

Capital invested by funds: $1.82B → $1.74B (-$74.7M)

Holders
188
Holders Change
+25
Holders Change %
+15.34%
% of All Funds
4.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
74
Reduced
53
Closed
15
Calls
$2.52M
Puts
$1.84M
Net Calls
+$683K
Net Calls Change
-$6.05M
Name Holding Trade Value Shares
Change
Change in
Stake
AB
151
Amalgamated Bank
New York
$220K +$13.3K +252 +6%
SCM
152
Stevens Capital Management
Pennsylvania
$202K +$201K +3,823 New
EP
153
Elkfork Partners
Oregon
$199K +$16.2K +308 +9%
LIA
154
LS Investment Advisors
Michigan
$188K +$131K +2,494 +233%
PNC Financial Services Group
155
PNC Financial Services Group
Pennsylvania
$176K +$147K +2,781 +494%
Victory Capital Management
156
Victory Capital Management
Texas
$162K -$28.8M -545,743 -99%
Russell Investments Group
157
Russell Investments Group
United Kingdom
$159K
GHCM
158
Glen Harbor Capital Management
California
$157K +$12.8K +242 +9%
RCM
159
Riverhead Capital Management
Delaware
$129K +$10.5K +200 +9%
AIP
160
Ameritas Investment Partners
Nebraska
$127K
NA
161
Neuburgh Advisers
California
$114K +$9.28K +176 +9%
Federated Hermes
162
Federated Hermes
Pennsylvania
$100K +$1.58K +30 +2%
GWM
163
Geneos Wealth Management
Colorado
$95K
PCM
164
Prelude Capital Management
New York
$90K
US Bancorp
165
US Bancorp
Minnesota
$78K -$14K -265 -15%
Zurich Cantonal Bank
166
Zurich Cantonal Bank
Switzerland
$70K +$18.9K +359 +37%
II
167
Inspire Investing
Idaho
$56K +$55.7K +1,056 New
SNT
168
Security National Trust
West Virginia
$53K
Macquarie Group
169
Macquarie Group
Australia
$47K +$47.4K +900 New
AG
170
Advisor Group
Arizona
$39K -$33.5K -636 -46%
VCM
171
Versant Capital Management
Arizona
$35K -$1.05K -20 -3%
SWA
172
Sutton Wealth Advisors
Florida
$25.2K
RAM
173
Riggs Asset Management
Pennsylvania
$24K
GXMC
174
Global X Management Company
New York
$23K +$5.22K +99 +29%
DCM
175
Delpha Capital Management
New York
$18K +$18K +342 New

AMED Hedge Fund Activity: Q4 2017 in Review

188 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2017, worth a combined $1.74B — down 4.1% from $1.82B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new AMED positions and 15 closed out — a net gain of 25 holders — while 74 added to existing stakes and 53 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $30.3M. The largest seller was BlackRock, cutting an estimated $31.7M.

  • 188 institutional investors held Amedisys (AMED) as of Q4 2017, up from 163 in Q3 2017.
  • Funds reported $1.74B of Amedisys stock for Q4 2017, down 4.1% quarter-over-quarter.
  • 40 funds opened new Amedisys positions in Q4 2017 and 15 closed out, a net change of +25 holders.
  • The largest Amedisys buyer in Q4 2017 was Columbia Wanger Asset Management, an estimated $30.3M added.
  • The largest Amedisys seller in Q4 2017 was BlackRock, an estimated $31.7M sold.

Based on aggregated 13F filings for Q4 2017.